15th Annual HMO Research Network Conference Agenda

Site Map | Home

a g e n d a

	The 15th Annual HMO Research Network Conference “Clinical Effectiveness: Leadership in Comparative Effectiveness and Translational Research” Sunday, April 26 – Wednesday, April 29, 2009 Geisinger Center for Health Research		Agenda Details Saturday \| Sunday \| Monday \| Tuesday \| Wednesday

	Host Geisinger Center for Health Research, Danville, PA Chair, Walter F. Stewart, PhD, MPH

	FINAL Agenda (PDF, 80KB)

Saturday, April 25 — Pine Barn Inn

	6–8 pm		Early Arrival Get Together at the Pine Barn Inn
	Montour Room




	7–8:30 pm		XS–1 HMORN _ ALS Grant Meeting – Zahra Daar
	Pine Barn Inn: Library

Sunday, April 26 — Center for Health Research

This year’s meeting begins on Sunday, April 26 with the Board Meeting scheduled from Noon to 8 p.m. and opportunities for ancillary meetings. The HMORN Information Desk will be open from 1:30 to 5 p.m.

	8 am–3 pm		XS–1 CRN Cancer Communication Research
	Multi-Purpose 2		Center (CCRC) – Sarah Madrid

	12–2 pm		XS–2 Socioeconomic Diversity in Integrated
	Multi-Purpose 3		Healthcare Delivery Systems and Racial
			Disparities SIG Meeting – Chyke Doubeni
			The first part of this meeting will be devoted to the business aspects of the pilot on the association between Area-based SES and Preventive Health Care. The second half will be devoted to discussions about a follow-up project (Racial Disparities SIG).

	1:30–5 pm		Conference Registration desk open
	Lobby


	Noon–8 pm		XS–3 HMORN Board of Governors Lunch, Dinner and
	Executive		Meeting
	Board Room Closed Meeting		Agenda and materials will be emailed to all board members prior to the meeting.



	3–5 pm		XS–4 Special Interest Group on Patient Centered
	Multi-Purpose 3		Communication and Cancer – Kathleen Mazor and Neeraj Arora

	6–8 pm		XS–5 Funded CRN3 Pilot Projects: What next? –
	Multi-Purpose 3		Chyke Doubeni
	Open to All		We will briefly review the 5 CRN Pilot projects funded in CRN Year 10, discuss lessons learned, and discuss next steps for these pilots.

			Dinner is on your own this evening

	8–10 pm		XS–6 6 CRN Genomics GO Grant –Larry Kushi and
	Intermediate 3		Katrina Goddard
			This meeting is specifically for the CRN Executive Committee.

Monday, April 27 — Center for Health Research

The ‘core’ activities (in black type) are currently scheduled to begin with lunch (all meal information is in orange type) and a kick–off poster session followed by the first plenary session; Monday morning includes a number of ancillary meetings (in blue type). Monday afternoon and evening will include concurrent sessions (in purple type) and the opening reception. This year the reception will not include a meal but will include substantive hors d’oeuvres and opportunities for networking.The HMORN Information Desk will be open from 7 a.m. to 5 p.m.

Your host hotel serves a continental breakfast each day for your convenience. Please enjoy breakfast before arriving at the Conference each morning. Shuttle buses are scheduled to run every 15 minutes from your hotel to the Geisinger Campus.

	7 am–5 pm		Conference Registration desk open
	Lobby


	7–10:30 am		Poster Session 1 Set-Up
	Lobby

	8–9:30 am		XM–1 CVRN – Sue Hee Sung
	Multi-Purpose 3

	8–9:30 am		XM–2 Child Health Research Interest Group –
	Intermediate 1		Jonathan Finkelstein
			The goal of this meeting is to make connections among individuals interested in collaborative child health research, and gauge interest in setting up a pediatric mentor network across sites.

	8–11 am		XM–3 CRN Steering Committee – Leah Tuzzio
	Executive Board Room Closed Meeting		At the Cancer Research Network’s (CRN) Steering Committee meeting we will discuss governance and administrative issues related to the CRN. This meeting is only for the CRN Steering Committee and NCI colleagues.

	8:30–10:30 am		XM–4 HMORN Mental Health Research Network
	Pine Barn Inn: Montour Rm		Development – Greg Simon, Leif Solberg, and Enid Hunkler

	8:30–10:30 am		XM–5 IDEA Study Team Meeting – JoAnn Sperl-Hillen
	Intermediate 2

	9:30–10:30 am		XM–6 Cancer Research Network Meeting – Enhancing
	Pine Barn Inn: Library		Collaboration – Sherry Lee Lauf

	9:30–11 am		XM–7 Diabetes Multi-Center Research Consortium –
	Multi-Purpose 2		Mark Pierce

	9:30–11 am		XM–8 HMORN CERT/DEcIDE Steering Committee –
	Multi-Purpose 3		Kimberly Lane
	Closed Meeting		HMORN CERT/DEcIDE steering committee meeting to plan for 2009 and beyond.

	9:30–11 am		XM–9 HMORN Obesity SIG – Margaret Rukstalis
	Intermediate 4

	9:30–11 am		XM–10 Pharmacovigilance Programmers Meeting –
	Intermediate 3		Lisa Temposky

	9:30–11 am		XM–11 CVRN: Hypertension Data Team Workgroup –
	Intermediate 1		Pamela Sulmer

	11 am–noon		Lunch

	Hospitality Tent

	11:30 am–noon		Poster Session 1
	Lobby

	Noon		Welcome to the 2009 HMORN Annual Conference
	Auditorium		Buzz Stewart, Bruce Hamory, and Richard Gilfillan

	12:10–1:45 pm		Plenary I: Comparative Effectiveness Research:
	Auditorium		Federal Funding and Industry Views


			A recent Congressional Research Services report noted that “Comparative clinical effectiveness research has been discussed as a source of information for health care decision makers that may aid them in reaching evidence based decisions…” Diverse governmental and non-governmental organizations have publicly expressed their support and reservations about comparative effectiveness research. Legislation has recently been passed by Congress to commit substantial resources in support of comparative effectiveness research. While publicly supported by many governmental and non-governmental entities in the abstract, there are many challenges to comparative effectiveness research and translation of findings to practice. The debate and practice of CE research is highly relevant to HMORN as it represents an important area of current research and a unique strength of the Network. The landscape has shifted in the last 4 months. Dialogue about comparative clinical effectiveness research is highly visible. Important questions regarding priorities for research, the sources of funding for such research, and federal and private sector oversight, among others, are under discussion. Dr. Gail Wilensky, PhD will use the first half of this session to provide an overview of the Federal legislative landscape and discuss the status and likelihood of what will be passed by Congress. The presentation and discussion will offer researchers and administrators a unique opportunity to understand one of the most important advances in research funding that is directly relevant to the Network. Dr. Gail Wilensky is widely recognized for her policy work on comparative effectiveness and the need to build a sustainable and effective process of creating evidence that helps patients and providers make the best choices in health care. Views on the value of comparative effectiveness and cost effectiveness research vary among governmental, non-governmental, health care providers, industry, and others. The second half of this session will involve a panel discussion by industry representatives, presenting their views on the value, application, and concerns about comparative and cost effectiveness research.

			Comparative Effectiveness Research: Federal Funding *Gail Wilensky, PhD* Project HOPE

			Industry Views on Comparative Effectiveness Research Moderators: Walter Stewart, PhD, MPH Geisinger Center for Health Research *Richard Gilfillan, MD* President & CEO, Geisinger Health Plan

			Panel Members: *Christina Farup, MD* Vice President, Evidence Based Medicine, Johnson & Johnson *Dean E. Hakanson, MD* Vice President, Healthcare Access, Bristol Myers Squibb *Greg Rossi, PhD* Senior Director, Health Economics and Outcomes Research, Genentech Inc

	1:30–2 pm		Poster Session 1 (continued)
	Lobby

	2– 3:30 pm		C–A1 HMORN Administrator's Annual Review and

	Focus Group		Planning – Tim O’Bar, Ella Thompson, Kate Rardin
			The administrator's group will review the activities and projects that were planned during the 2008 conference and solicit ideas for the coming year. Please join in the discussion—we'd love to have participation from all member organizations. Current activities being discussed include Effort Reporting, Subcontract and Data Use Agreement Templates, Website Development, Organizational Structures and Benchmarking, Recruitment and Development of Research Administration Staff.

	2– 3:30 pm		C–A2 Comparative Effectiveness and Health
	Multi-Purpose 2		Services I: Support Systems and Innovation to
			Improve Care Delivery and Quality – Robert Greenlee, JB Jones
			This session will focus on primary care based medical home initiatives and quality improvement or financial ROIs.

			Virtual Consults in an Electronic Medical Record: Physician Use, Satisfaction, and Learnings
			David W. Price, MD; Kaiser Permanente Colorado

			Virtual Consult Use in an Electronic Medical Record: Descriptive Statistics at Mid-point of Study
			Ted E. Palen, MD, PhD, MSPH; Kaiser Permanente Colorado

			A Comparative Assessment of Two Workflow Models for Patient Completed Computerized Questionnaires
			Eric D Newman, MD; Geisinger Health System

			The Geisinger Transitions of Care Initiative, Overview of an Interdisciplinary Quality Improvement Process
			John B. Bulger, DO; Geisinger Health System

	2– 3:30 pm		C–A3 Behavioral Health – Sharon Larson, Nancy
	Multi-Purpose 1		Sherwood
			This session will focus on sustainable practice-based or community-based interventions for improving health.

			The Effect of an Automated Reminder Call Intervention on Completion of Fecal Occult Blood Testing (FOBT)
			David M. Mosen, PhD, MPH; Kaiser Permanente Northwest

			How Do the Best Physicians Get Diabetes Patients to Glycemic Goals?
			William A. Rush, PhD; HealthPartners Research Foundation

			Media Messages About Cancer: What Do People Understand?
			Laura Saccoccio, BS; Meyers Primary Care Institute

			The Role of Family Disease History and Perceived Risk of Disease in Change of Fruit and Vegetable Intake Over 12 Months
			Gwen Alexander, PhD; Henry Ford Health System

	2– 3:30 pm		C–A4 Pharmaco-Epidemiology – Cathy McCarty,
	Multi-Purpose 3		Marsha Raebel
			This session will focus on treatment adherence and formulary prescribing.

			Computerized Clinical Decision Support During Drug Ordering for Long-term Residents with Renal Insufficiency
			Terry S. Field, DSc; Meyers Primary Care Institute

			Do Automated Phone Calls Improve Adherence to Inhaled Corticosteroids (ICS)
			William M. Vollmer, PhD; Kaiser Permanente Northwest

			Risks to the Newborn Associated with In-Utero Exposure to Beta-Blockers & Calcium-Channel Blockers
			Robert L. Davis, MD, MPH; Kaiser Permanente Northwest

	2– 3:30 pm		C–A5 CRN Scholars Session–Research Integrity and
	Auditorium		Ethical Quandaries – Suzanne Fletcher
			This interactive session will utilize a case study approach to explore issues related to promoting research integrity. Two cases will be presented by CRN Scholars, and discussion will be led by a panel of senior researchers.

			Planning Committee: Laura Coleman, PhD, RD;Marshfield Clinic Research Foundation Reina Haque PhD, MPH; Kaiser Permanente Southern California Scott Robinson, PhD; Lovelace Clinic Foundation Robin Whitebird, PhD, MSW; HealthPartners Research Foundation

			Presenters: Laurie Habel, PhD; Kaiser Permanente Northern California Reina Haque PhD, MPH; Kaiser Permanente Southern California Nirav Shah, MD, MPH; Geisinger Health System, Center for Health Research

			Discussants will include: Martin Brown, PhD; NCI Rich Platt, MD, MSc; Harvard Pilgrim Karen Margolis, MD, MPH; HealthPartners Research Foundation Joe Selby,MD, MPH; Kaiser Permanente Northern California

	3:30–3:45 pm		Beverage Break


	Hospitality Tent

	3:45–5:15 pm		C–B1 Regulatory/Compliance: Hot Topics in Clinical

	Focus Group		Research Compliance – Sherry Lauf, Ted Palen
			Using an Electronic Medical Record to Document and Track Research Activities and Expenditures
			Ted E. Palen, MD, PhD, MSPH; Kaiser Permanente Colorado

	3:45–5:15 pm		C–B2 Comparative Effectiveness and Health
	Multi-Purpose 2		Services II: Patient Centered Care – Robert Reid
			This session will focus on primary care initiatives that include the patient as a key member of the health care team (shared decision-making, etc).

			Disease and Care Management for Multimorbid Patients in an Integrated System: How Much is Too Much?
			Jennifer L. Ellis, MBA, MSPH; Kaiser Permanente Colorado

			Measuring the Effect of a Patient-Centered Health Initiative on Clinic-level Outcomes
			Jove Graham, PhD; Geisinger Center for Health Research

			Patient and Clinician Experience in a Patient-Centered Medical Home Demonstration
			Tyler R. Ross, MA; Group Health

			Helping Women Be a Part of the Answer: Cognitive Interviews to Assess Attitudes on Hormone Therapy
			Eric J. Bieber, MD, MHCM; Geisinger Health System

	3:45–5:15 pm		C–B3 Genetic Epidemiology – Katrina Goddard,
	Multi-Purpose 1		Bob Davis
			This session will focus on effect modification of genetic factors for treatment decisions.

			Variation in Seven Obesity-Related Genes and Risk of Postmenopausal Breast Cancer
			Heather S. Feigelson, PhD, MPH; Kaiser Permanente Colorado

			Association of FTO, INSIG2, MC4R, and PCSK1 Obesity SNPs with Binge Eating in Morbidly Obese Patients
			Glenn Gerhard, MD; Weis Center for Research

			Association of Epidemiologic and Genetic Factors with Adbominal Aortic Aneurysm (AAA)
			Diane T. Smelser, PhD; Geisinger Center for Health Research

			Media Analysis of Genetic Testing Information for Common Disease Presented to the Public
			Alanna Kulchak Rahm, MS; Kaiser Permanente Colorado

	3:45–5:15 pm		C–B4 Diabetes – Innovative Approaches to Treating
	Multi-Purpose 3		Diabetes – William Rush, Kristi Reynolds
			This session will focus on risk factors, treatment, and adherence of diabetes.

			Educator Experience with Group Interactive Dialogue to Educate and Activate (IDEA) using Conversation Maps
			JoAnn M. Sperl-Hillen, MD; HealthPartners Research Foundation

			Effect of Point-of-Care A1c Testing in Primary Care Clinics on Diabetes Medication Intensification
			Karen L. Margolis, MD, MPH; HealthPartners Research Foundation

			EMR-based Clinical Decision Support System Improved Glucose and Blood Pressure Control in Adults with Diabetes
			Patrick O'Connor, MD, MPH; HealthPartners Research Foundation

			Personalized Physician Learning Intervention Improved Glucose Control in Adults with Diabetes
			JoAnn M. Sperl-Hillen, MD; HealthPartners Research Foundation

	3:45–5:15 pm		XM–12 CVRN Collaboration Meeting – Zahra Daar
	Intermediate 4 Closed Meeting

	5:30–8 pm		Welcome Reception
	Foss Home

	7–9 pm		XM–13 Informal Project Management Session –
	Intermediate 4		Ella Thompson

	8–10 pm		Remove Poster Session 1
	Lobby

	8–10 pm		XM–14 VDW Implementation Group – Gene Hart,
	Multi-Purpose 3		Jeff Brown

Tuesday, April 28 — Center for Health Research

Tuesday will be solid ‘core’ meetings with meeting space available mainly in the evening. Tuesday will conclude with an evening of Blue Grass music and fun for your enjoyment.

	7 am–5 pm		Conference Registration desk open
	Lobby


	7–8 am		Poster Session 2 Set-Up
	Lobby

	7–8 am		XT–1 Health Literacy and Cancer Prevention – Do
	Intermediate 4		People Understand What They Hear – Kathleen Mazor
			Working Group Meeting

	7–8 am		XT–2 Pharmacovigilance Study Investigators Meeting
	Executive Board Room		– Lisa Temposky

	7–8 am		XT–3 DEcIDE Distributed Research Network Project –
	Multi-Purpose 3		Kimberly Lane
	Closed Meeting		Project meeting for the DEcIDE Distributed Research Network team

	8–8:30 am		Plenary II: State of the Network –
	Auditorium		Eric Larson, MD, MPH, MACP
			This annual presentation is delivered by the current Chair of the HMORN Governing Board and is intended to update HMORN members on deliberations and decisions made at the annual Board meeting which takes place the previous day. It will focus on new directions and infrastructure being developed by the HMORN to provide broad administrative and research support to members of the HMORN who wish to find collaborators at other partnering centers or to prepare collaborative proposals.

	8:30–9:30 am		Town Hall Meeting – Maggie Gunter, PhD
	Auditorium		Reactants
			Eric Larson, MD, MPH, MACP Walter Stewart, PhD, MPH; Geisinger Center for Health Andrew Nelson, MPH; HealthPartners Research Foundation Joseph Selby, MD, MPH; Kaiser Permanente Northern California

	9:30–9:45 am		Beverage Break

	Hospitality Tent

	9:45–11:15 am		C–C1 Informatics I: Natural Language Processing –

	Multi-Purpose 1		Ted Palen, Michael Klompas
			A Strategic Plan for Developing Natural Language Processing Capacity at HMORN Sites
			David S. Carrell, PhD; Group Health, Center for Health Studies

			Data Extraction from Text, Step 1: Preparing Test for Machine Processing
			David S. Carrell, PhD; Group Health

			Identifying Respiratory-related Clinical Conditions from ED Reports with Topaz
			Wendy W. Chapman, PhD; University of Pittsburgh

			Building a Health Services Information Technology Research Environment
			David W. Gehrum, BS; Geisinger Health System

	9:45–11:15 am		C–C2 Health Economics – Mark Hornbrook
	Focus Group		This session will focus on cost effectiveness analysis and ROI in the real world.

			Financial Assessment of a Comprehensive Cardiac Care Program for Patients with Occlusive Coronary Artery Disease
			Thomas Delate, PhD, MS; Kaiser Permanente Colorado

			Validation and Uses of the ACG-DX Predictive Modeling and Risk Adjustment Tool in an Israeli HMO
			Isaac Hoch, MD; Maccabi Healthcare Services

			Incidence-based Costs of Multiple HAART Switches among HIV-infected Patients in an HMO
			Richard T. Meenan, PhD, MPH, MBA; Kasier Permanente Northwest

	9:45–11:15 am		C–C3 Comparative Effectiveness Evidence and
	Multi-Purpose 2		Methods I – Nirav Shah, Hasan Rajab
			A Conditional Sequential Sampling Procedure for Drug Safety Surveillance
			Lingling Li, PhD; Harvard Pilgrim Health Care

			Increasingly Restrictive Definitions of Hyperkalemia Outcomes in a Database Study: Effect on Incidence Estimates
			Marsha A. Raebel, PharmD; Kaiser Permanente Colorado

			From Chart to CART: Improving Automated Case-Finding for Ectopic Pregnancy Using CART Analysis
			Delia Scholes, PhD; Group Health, Center for Health Studies

			Using Electronic Health Record Data to Predict Heart Failure Diagnosis
			Nirav R. Shah, MD, MPH; Geisinger Center for Health Research

	9:45–11:15 am		C–C4 Cancer – Reina Haque
	Multi-Purpose 3		This session will focus on surveillance, rates, and treatments.
			Statin Use and Risk of Basal Cell Carcinoma
			Maryam M. Asgari, MD, MPH; Kaiser Permanente Northern California

			Improving Survivorship Care for Long-term Colorectal Cancer Survivors: Key Findings of a 5-Year Study
			Carmit K. McMullen, PhD; Kaiser Permanente Northwest

			Examination of the Use of First-line Chemotherapy Regimens for Colorectal and Lung Cancer Impact of Patient Characteristics
			Debra P. Ritzwoller, PhD; Kaiser Permanente Colorado

			Trends in Breast Cancer Incidence in a Setting of Increased Mammography Screening and Decreased Use of Oral Estrogen Replacement Therapy
			Barbara G Silverman, MD, MPH; Maccabi Healthcare Services

	9:45–11:15 am		C–C5 New & Emerging Issues in Human Subjects
	Executive Board		Research – Andrea Cook, Nancy Moody
	Room		A session exploring issues arising at the forefront of human subject research (e.g. biorepositories, geocoding & privacy concerns).

	11:15 am –12:15 pm		Lunch

	Hospitality Tent

	11:15 am–12:15 pm		XT–4 SAEC Pilot Projects – Robert Davis
	Intermediate 4
	Closed Meeting

	11:45 am–12:15 pm		Poster Session 2
	Lobby

	12:15–1:30 pm		Plenary III: Comparative Effectiveness in Practice
	Auditorium		and AHRQ’s Role in Comparative Effectiveness Research – Scott R. Smith, PhD, MSPH, Director, Pharmaceutical Outcomes Research, Agency for Healthcare Research & Quality

			The importance of comparative effectiveness research was clearly demonstrated by the recent attention (and funding) targeted to this area in the American Recovery and Reinvestment Act (ARRA). The importance of relevant and timely comparative effectiveness research findings for health care decision makers is of particular significance when designing and conducting comparative effectiveness research. Anticipating the needs of health care decision makers, designing studies to reflect the realities of real world practice and patients, promoting innovative study designs, and incorporating findings into health care decisions are all challenges for comparative effectiveness research. This panel will discuss three related issues: The need for research with various stakeholder perspectives taken into account the types and levels of evidence required for different policy-relevant decisions How to best leverage HMORN and partner resources to respond to these challenges. Scott Smith will use the first half of this session to provide an overview of Comparative Effectiveness Research in the United States and AHRQ’s strategic approach to Comparative Effectiveness. Additional discussants include Joe Selby, Stephen Crystal, and Dave Hickam. Panel Members: Stephen Crystal, PhD Division Head on Aging, Institute for Health, Health Care Policy and Aging Research at Rutgers University Joe Selby, MD, MPH Director of the Division of Research (DOR), Kaiser Permanente Northern California David Hickam

	1:30–2 pm		Poster Session 2 (continued)
	Lobby

	2–3:30 pm		C–D1 Lean Management: Practice for Research


	Multi-Purpose 1		Administration – Helga Ding
			Moving from Islands of Excellence in Oceans of Secrecy to Supporting Scientific Excellence as a Team
			Helga S. Ding, DDS, MBA, MHA; Group Health

	2–3:30 pm		C–D2 Cardiovascular Disease – Karen Margolis,


	Multi-Purpose 2		Katherine Newton
			The session will focus on risk factors, medications, and prevention of cardiovascular disease.

			Outcomes Associated with Thiazide Combinations for 2nd-line Treatment of Hypertension in Older Patients
			Robert D. Langer, MD, MPH; Geisinger Center for Health Research

			Integrating Clinical Trial Findings into Practice Through Risk Stratification: The Case of Heart Failure Management
			David H. Smith, RPh, MHA, PhD; Kaiser Permanente Northwest

			Effects of Race and Comorbidities on Differences in Blood Pressure Control in Urban and Rural Populations
			Robert D. Langer, MD, MPH; Geisinger Center for Health Research

			Persistence with Statins and All-cause mortality: A Population-based Cohort Study
			Gabriel Chodick, PhD; Maccabi Healthcare Services

	2–3:30 pm		C–D3 Informatics II: Distributed Computing –


	Multi-Purpose 3		Ted Palen, Michael Klompas
			Development and Implementation of Secure Linear Regression on Distributed Databases
			Fang Zhang, PhD; Harvard Pilgrim Health Care

			Syndromic Surveillance Reporting via CDCs Public Health Information Grid
			Michael Klompas, MD, MPH, RCPSC; Harvard Pilgrim Health Care

			Developing a Distributed Research Network to Conduct Population-based Studies and Safety Surveillance
			John H. Holmes, PhD, FACMI; University of Pennsylvania School of Medicine

			Governing Access to a Distributed Research Network's Data Resources
			Beth L. Syat, MPH; Harvard Pilgrim Health Care

	2–3:30 pm		XT–5 Peer Review at NIH: Opportunities and
	Auditorium Open to All		Challenges – Cheryl Kitt, PhD, Deputy Director, Center for Scientific Review at the NIH
			The NIH Center for Scientific Review (CSR) organizes the peer review groups that evaluate the majority of grant applications submitted to the National Institutes of Health. Since 1946, CSR’s mission has been to see that NIH grant applications receive fair, independent, expert, and timely reviews so NIH can fund the most promising research. CSR also receives all incoming applications and assigns them to the NIH institutes and centers that fund grants. The CSR is available online at www.csr.nih.gov. Dr. Kitt will discuss meeting procedures at NIH, and provide information on the challenges, opportunities, and enhancements facing the peer review process. This is a rare opportunity for post-docs and young investigators to gain an inside perspective and ask questions on the preferences of the Scientific Review Committee.

	3:30–3:45 pm		Beverage Break

	Hospitality Tent

	3:45–5:30 pm		Plenary IV: System Level Health Care Innovation
	Auditorium		and Research
			The U.S. healthcare system is beset with persistent structural challenges that continue to erode the quality of care while simultaneously increasing cost and hindering access. In contrast to other markets, health care is not structured in a way in which the cost of goods and services decreases over time in parallel with increases in quality and access. Structural changes in how care is delivered and financed will be required to transform health care to behave in a manner that is consistent with what typically happens in other markets. Such changes are likely to involve a fundamental shift away from the traditional role of what it means to be a provider and a patient in the U.S. healthcare system and a parallel re-engineering of the way in which health care is delivered. Integrated delivery systems are leaders in the use of information technology in health care. Importantly, these systems are also uniquely positioned to play a leading role in evolving 21st century care models that address the fundamental need to deliver high quality outcomes at a lower cost. A number of factors in the 21st century are likely to force changes in how health care is delivered and financed. Specifically, per–capita costs are increasing, patient average age is increasing, per-capita clinician supply is decreasing, and below-cost payers (e.g., Medicare, Medicaid) are becoming the increasingly predominant payor. In many ways, integrated delivery systems are a microcosm of the larger U.S. healthcare system, struggling to meet the challenge of aligning incentives and processes to satisfy its major stakeholders. More importantly, HMO Research Network health systems have a unique asset in their research centers and the potential opportunities to more directly engage leadership of these centers in system level research and innovation. This plenary session will focus on: How integrated delivery systems can institutionalize innovation, using information technology and other means to re-engineer care processes and transforming how health care is used and delivered How to identify opportunities to simultaneously improve quality and access and to address the needs of key stakeholders (i.e., patient, payer, provider), including a dominant role for the consumer The role that research centers have in continuously fostering such changes This session will begin with introductory remarks from the Moderator, who will define the targets for 21st century care, followed by presentation from two system leaders (i.e., Dr. Paulus and Mr. Austin) on approaches to innovation and institutionalizing innovation as a core feature of 21st century health care systems. Following, Dr. Casalino will offer an expert but outsider’s (i.e., outside of an integrated delivery systems) perspective on organizational challenges with motivating and sustaining innovation and the extent to which innovation within integrated delivery systems is likely to influence the broader market.

			Moderator: Richard Gilfillan, MD, President & CEO, Geisinger Health Plan *Ron Paulus, MD, MBA* Chief Technology and Innovation Officer, Geisinger Health System *Brian Austin* MacColl Institute for Healthcare Innovation, Group Health Cooperative *Larry Casalino, MD, PhD* Chief of the Division of Outcomes and Effectiveness Research, Weill Cornell Medical College

			Dinner is on your own this evening *if not attending the Blue Grass Night*

	5:30–6:30 pm		XT–6 Family History SIG – Jody Jackson
	Intermediate 2

	5:30–7 pm		XT–7 Increasing Participation in Cancer Clinical Trial
	Intermediate 3		Project Meeting – Carol Somkin

	5:30–7 pm		XT–8 CRN Scholars Reception - Jane Colagiovanni
	Pine Barn Inn: Montour Room

	5:30–7:30 pm		XT–9 Medical Radiation Induced Cancers:
	Intermediate 1		Background and Planning Committee Meeting for CRN Grant – Rebecca Smith-Bindman

	5:30–9 pm		Remove Poster Session 2
	Lobby

	6–7:30 pm		XT–10 Workshop: Designing Translational Studies In
	Intermediate 4		Genetic Epidemiology – Porat Erlich and Robert Davis

	7–8:30 pm		XT–11 Investigator’s VDW Training – Terry Field,
	Intermediate 2 Open to All		Deb Ritzwoller, Gene Hart

	7–9 pm		Blue Grass Night
	Multi-Purpose 1-2-3

	7:30–9 pm		XT–12 Medication Use in Pregnancy & Birth
	Executive Board Room		Outcomes Program – Kim Lane

Wednesday, April 29 — Center for Health Research

Wednesday will be solid ‘core’ meetings with meeting space available mainly in the afternoon. Our final plenary session of the conference is scheduled from 9 to 10:30 a.m. Wednesday morning will start off with a 5K Run / 1K Walk.

	7 am–Noon		Conference Registration desk open
	Lobby

	7–8 am		5K Run/1K Walk
	Hess Field

	7–9 am		XW–1 Cancer Prevention Index Project - Tom Vogt
	Intermediate 4

	9–10:30 am		Plenary V: Young Investigators –
	Auditorium		Eric Larson, MD, MPH, MACP
			Young investigators are the HMORN’s greatest asset and the source of future leadership. The Network is committed to the success of young investigators through effective mentoring, access to local and shared data sources, fostering cross-site collaborations, and recognition. The purpose of this plenary is to showcase work of four young investigators competitively selected for their work

			Oral Presentations: *Sascha Dublin, MD, PhD* Group Health Center for Health Studies *Kathleen E. Walsh, MD, MSc* Meyers Primary Care Institute, University of Massachusetts Medical School *Frank Wharam, MB, BCh, BAO, MPH* Harvard Pilgrim Healthcare *JB Jones, PhD, MBA* Geisinger Center for Health Research

			Honorable Mentions: *Laura Coleman, PhD, RD* Marshfield Clinic Research Foundation *Thomas Flottemesch, BA, MS, PhD* HealthPartners Research Foundation *Kim Vesco, MD, MPH* Kaiser Permanente Northwest, The Center for Health Research *Suma Vupputuri, PhD, MPH* Kaiser Permanente Georgia, The Center for Health Research

	10:45–noon		Box Lunch Optional

	Hospitality Tent

	12:30 –5 pm		XW–2 CRN Scholars Meeting – Jane Colagiovanni
	Executive Board Room

	6–9 pm		XW–4 Scholar’s Dinner – Jane Colagiovanni
	Pine Barn Inn: Montour Room

Top

FINAL Agenda (PDF, 80KB)